{"transactions":[{"id":4634422,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:20:11.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":32012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32012,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":32012},"source":{"system":"sec-edgar","filing":"0001878313-26-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000100/form4.xml","form_type":"4"}},{"id":718385,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:09:21.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":26355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26355,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":26355},"source":{"system":"sec-edgar","filing":"0001878313-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000069/form4.xml","form_type":"4"}},{"id":819907,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:50:21.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":27258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":27258,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":27258},"source":{"system":"sec-edgar","filing":"0001878313-26-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000031/form4.xml","form_type":"4"}},{"id":951972,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:44:40.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":24060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":24060,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":24060},"source":{"system":"sec-edgar","filing":"0001878313-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000018/form4.xml","form_type":"4"}},{"id":1023449,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:29:04.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":20459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20459,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":20459},"source":{"system":"sec-edgar","filing":"0001878313-25-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000035/form4.xml","form_type":"4"}},{"id":1095568,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:13:00.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":20380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20380,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":20380},"source":{"system":"sec-edgar","filing":"0001127602-25-018648","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018648/form4.xml","form_type":"4"}},{"id":1175722,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:41:05.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":20291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":20291,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":20291},"source":{"system":"sec-edgar","filing":"0001127602-25-011809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011809/form4.xml","form_type":"4"}},{"id":1315324,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-01-03T21:05:27.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":10225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":10225,"derivative":{"exercise_price":1.98,"exercise_date":"2024-12-31","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":10225},"source":{"system":"sec-edgar","filing":"0001127602-25-000375","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225000375/form4.xml","form_type":"4"}},{"id":1394761,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-10-02T20:45:24.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":7232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date."}],"balance_after":7232,"derivative":{"exercise_price":2.81,"exercise_date":"2024-09-30","expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":7232},"source":{"system":"sec-edgar","filing":"0001127602-24-024933","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224024933/form4.xml","form_type":"4"}},{"id":1463432,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-07-02T20:08:43.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":5728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":5728,"derivative":{"exercise_price":3.42,"exercise_date":"2024-06-30","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":5728},"source":{"system":"sec-edgar","filing":"0001127602-24-019835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224019835/form4.xml","form_type":"4"}},{"id":1553960,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-04-02T20:52:23.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":9193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":9193,"derivative":{"exercise_price":2.2,"exercise_date":"2024-03-31","expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":9193},"source":{"system":"sec-edgar","filing":"0001127602-24-011875","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224011875/form4.xml","form_type":"4"}},{"id":1693268,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-01-04T01:57:31.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":15418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":15418,"derivative":{"exercise_price":1.17,"exercise_date":"2023-12-31","expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":15418},"source":{"system":"sec-edgar","filing":"0001127602-24-000643","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224000643/form4.xml","form_type":"4"}},{"id":1767933,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-10-03T20:14:52.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":8378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":8378,"derivative":{"exercise_price":2.2,"exercise_date":"2023-09-30","expiration_date":"2033-09-30","underlying":"Common Stock","underlying_shares":8378},"source":{"system":"sec-edgar","filing":"0001127602-23-025164","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223025164/form4.xml","form_type":"4"}},{"id":1836810,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-07-05T12:13:07.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":8910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":8910,"derivative":{"exercise_price":2.2,"exercise_date":"2023-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":8910},"source":{"system":"sec-edgar","filing":"0001127602-23-019768","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223019768/form4.xml","form_type":"4"}},{"id":1928960,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32975,"kind":"person","name":"Theagene Jean-Manasse","position":1,"cik":"0001969857","reported_name":"Theagene Jean-Manasse","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-04-04T10:30:53.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":945,"derivative":{"exercise_price":3.46,"exercise_date":"2023-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":945},"source":{"system":"sec-edgar","filing":"0001127602-23-012013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223012013/form4.xml","form_type":"4"}}]}